| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2970918 | The Journal of Heart and Lung Transplantation | 2012 | 7 Pages |
Abstract
Newer generations of MSCT (64- or 256-row) have a good NPV and may represent an alternative to invasive CA to rule out significant (>50%) coronary vasculopathy in heart transplant patients, despite a low PPV.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Olivier MD, Dan MD, Shaïda MD, Flor MD, Rehda MD, Fabrizio MD, Gerard MD,PhD, Claude MD, Iradj MD, Jean Philippe MD, Alain MD, Philippe MD,PhD,